Denmark acted coordinator in EU Commission's work on decentralized clinical trials

New guidelines for decentralized clinical trials in the EU have been agreed to by participating parties, and the Danish representation claims to have had a special role.
Photo: Lægemiddelstyrelsen/pr
Photo: Lægemiddelstyrelsen/pr
by ulrich quistgaard, translated by daniel pedersen

The Danish Medicines Agency has acted as coordinator in the work behind new EU guidelines for decentralized clinical trials, the agency writes in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading